MSc Pharmaceutical Science

Postgraduate, Part-time

Explore drug development, manufacture and production and enhance your prospects for a career as a drug discovery or development scientist in the pharmaceutical, healthcare, nutraceutical or bioscience industries.

  • Napier code:

    74720MM

  • Course type:

    Part-time

  • Duration:

    2 Years

  • Award:

    MSc

  • Location:

    Sighthill campus

Ask about this course
About you
Enter first name
*
Enter last name
*
*
*
*
*
*

Course introduction

This course provides expert critical and technical knowledge related to the development, analysis and production of medicines, the drug industry and regulatory affairs.

You'll study recent trends in chemical, biological and biotechnological therapeutics and evaluate the latest technologies used in the pharmaceutical industry.

You'll also gain an understanding of the processes and methods used in clinical trials and the regulation of medicines and acquire the skills and knowledge to pursue your career in pharmaceutical science.

This is a part-time course, starting in September or January, with flexibility in the number of taught modules taken in each trimester.

This course is eligible for a SFC funded place for Scottish and EU students – please see the SFC funding page for more information on how to apply.


pharmaceutical science

This course provides the opportunity to acquire all the attributes necessary for a successful career in pharmaceutical science, undertaking lead research and development, or analytical management roles in the drug and healthcare industries.

You’ll acquire broad knowledge of contemporary, integrated drug discovery strategies and acquire the necessary skills to communicate effectively across the key, diverse component disciplines with other professional scientists and non-specialist audiences.

You’ll develop broad knowledge of current pharmaceutical analysis and quality control strategies and will learn about GMP and GLP compliance. You’ll also gain an in-depth critical understanding of current research in biotechnology and pharmaceutical science.

There is an emphasis on developing your practical laboratory skills with various opportunities for hands-on experience in a range of current techniques and practices including specialist equipment such as HPLC, UV/Vis, and FTIR. In your final trimester you’ll undertake an independent project within a vibrant research team, allowing you to apply and further develop your technical, research and professional skills. There may be the opportunity to conduct your research project externally in a relevant organisation or pharmaceutical industry in the UK or overseas.

You‘ll also develop key skills including communication, problem solving, team work, project management, and leadership. You’ll learn through interactive lectures, workshops, tutorials, site visits and laboratory sessions, and by engaging with guided independent study. A variety of assessment tools are used to enhance and evaluate your learning.

This is a part-time course which you can start in September or January with flexibility in the number of taught modules taken in each trimester. The project may be carried out over one or two trimesters. There may also be some opportunities to study abroad.

This programme is also available as a Masters by Research.

Subjects include

  • Current practice in drug development
  • Molecular pharmacology and toxicology
  • Current topics in pharmaceutical science
  • Research skills
  • Quality Control and Pharmaceutical Analysis
  • Drug design and chemotherapy
  • Research project

Study modules mentioned above are indicative only. Some changes may occur between now and the time that you study.

Full information on this is available in our disclaimer.

A large proportion of our graduates enter laboratory based and research management based product development work. They are employed in industries ranging from the big pharmaceutical companies to developing biotech companies; contract drug testing companies and service providers to the pharmaceutical and healthcare industries; hospital laboratories, NHS and local government.

If you currently work in a relevant sector, this course will enhance your prospects for career progression. This qualification also provides a sound platform for study to PhD level in pharmaceutical and biomolecular sciences and an academic career.


The entry requirement for this course is a Bachelor (Honours) Degree at a 2:2 or above. We look for applicants to have a background in  bio-molecular sciences in order to be eligible for this programme. The following acceptable degree background are: pharmacy; pharmacology, pharmaceutical or medicinal chemistry; biological or biomedical sciences; chemistry; immunology; biotechnology; genetics; virology; molecular biology; forensic science.

We may also consider degree-equivalent qualifications, as will applicants without Honours degree equivalence but who have appropriate experience gained in the pharmaceutical or healthcare industries.

English language requirements

If your first language isn't English, you'll normally need to undertake an approved English language test and our minimum English language requirements will apply.

This may not apply if you have completed all your school qualifications in English, or your undergraduate degree was taught and examined in English (within two years of starting your postgraduate course). Check our country pages to find out if this applies to you.


If English is not your first language, it is usually required that you sit an English language test in order to gain entry onto our postgraduate programmes.

This course requires the standard IELTS 6.0 with no individual component score of less than 5.5 or equivalent.

Our entry requirements indicate the minimum qualifications with which we normally accept students. Competition for places varies from year to year and you aren't guaranteed a place if you meet the minimum qualifications.

International students

If your qualifications aren't listed above, visit our country pages to get entry requirements for your country.

Please note that non-EU international students are unable to enrol onto the following courses:

BN Nursing/MN Nursing (Adult, Child, Mental Health or Learning Disability)

BM Midwifery/MM Midwifery

Admissions policies

We are committed to being as accessible as possible to anyone who wants to achieve higher education.

Our admissions policies will help you understand our admissions procedures and how decisions are made.


Tuition fees
Students from 2017/18 2018/19
Home/EU Stage 1 £1,700 £2,660
Home/EU Stage 2 £2,050 £3,190
====== ======
Home EU - Total Fee £3,750 £5,850
============================================================================== ====== ======
Stage 1 £6,610 £6,800
Stage 2 £8,080 £8,350
====== ======
Overseas - Total Fee £14,690 £15,150
============================================================================== ====== ======
This course comprises of 180 credits from taught modules and a dissertation. The total fee you will pay is dependant upon the exit award you wish to achieve.

Frequently Asked Questions about Fees.

Information of Bursaries and Scholarships.

Information about SFC (Scottish Funding Council) available for this course.

Modules that you will study* as part of this course

Biotechnology & Drug Discovery ( MIC11101 )

High throughput screening strategies for new drugs/targets: genomics, microarray technology; proteomics, phage display technology; Site-directed mutagenesis and protein engineering on enzyme specificity and pattern of inhibition by new drugs. Biotransformations vs chemical synthesis; Glycobiology; Culture systems - batch vs continuous; mammalian, plant, bacterial culture systems; Antisense RNA; GDEPT and VDEPT; Nanotechnology: mechano-chemical properties

Further information

Clinical Pharmacology ( BMS11108 )

General Introduction (Pharmacokinetics, Pharmacoynamics, Therapeutic Monitoring), Drug Interactions, Toxicology and Adverse Drug Reactions (Causation, Pharmacovigilance, Pharmacoepidemiology, Allergy, the Effects of Prolonged Administration, Effects on Reproduction, etc.), Poisoning and Overdoses, and Specialist Topic Areas (Neuroscience, Cardiovascular and Endocrine Biology, and Alcohol).

Further information

Current Practice in Drug Development ( BMS11104 )

Origins and new sources of drugs; natural products and new pharmaceuticals; the drug discovery and development process. Molecular modelling. Stereochemistry: a source of problems in medicinal chemistry. Structure-based drug design; pharmacophore-based drug design; QSAR. Physicochemical properties and drug design: electronic factors, lipophilicity, partition coefficient, steric parameters, prediction of drug-receptor interactions, ligand binding studies. Drug formulation, prodrugs. Computational techniques: analysis of conformational space, molecular graphics and the visualisation of molecules. Molecular diversity. Combinatorial libraries and modern methods of synthesis. Current approaches to the chemotherapeutic treatment of (selected) diseases: cardiovascular disease, inflammation, cancer, viral- and bacterial- infection, diabetes, asthma, cognitive disorders. Legislation: regulatory requirements. Intellectual property and patent protection of new pharmaceuticals.

Further information

Current Topics in Pharmaceutical Science ( BMS11109 )

Phases of clinical development of new drugs, Official regulation of medicines, Formulation, classification and naming of drugs. Pharmaco-economics. Introductory ethics and the history of "ethical" regulation. Legal Implications of being "unethical". Perception of pharmaceuticals and the pharmaceutical industry by society. Exploration of specific topics, e.g. Drug testing, when testing goes wrong, the ethics of testing in different countries, the use of animal models in drug development and testing.

Further information

Drug Design and Chemotherapy ( BMS11105 )

Emphasis on: molecular targets in cancer: characterisation and structure of biological targets (genes; enzymes; receptors; nucleic acids). Design, synthesis and mechanism of action of inhibitors of telomerase, the G-quadruplex, DNA-topoisomerases, matrix metalloproteinases. Targeted therapies, drug delivery mechanisms, design of prodrugs; macromolecular prodrugs and nanoconjugates. Synthetic oligonucleotides, PNAs, DNA-and RNA-binding ligands: design and applications. Synthesis and development of non-nucleoside antiviral agents: HIV integrase inhibitors, protease inhibitors. Peptoids and peptide mimics. Mechanisms of intrinsic and acquired drug resistance and MDR. Contemporary drug design to combat resistant bacterial and protozoal infections. Laboratory work in selected drug synthesis, methods of purification and characterisation; solution and solid- phase combinatorial peptide methodology and biological (including enzyme) assays; molecular graphics.

Further information

Research Skills ( MIC11107 )

DNA purification, restriction and quantification; Cloning – vectors, ligation, screening and analysis of clones; Gene expression and protein purification; Protein analysis – quantification, detection and mass spectrometry; Principles of nucleic acid hybridisation and DNA synthesis to applications in PCR, sequencing microarrays and gene silencing techniques (RNA interference); In silico analysis and manipulation of RNA, DNA and protein sequence information (bioinformatics); “-omics” – comparative and functional genomics, proteomics.

Further information

* These are indicative only and reflect the course structure in the current academic year. Some changes may occur between now and the time that you study.

This is a versatile and industry relevant course that deals with various aspects of the world of Pharmaceutical Science.

Maria Gauci

Teaching Associate and former Quality Control Analyst